Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Overview of measles and mumps vaccine: origin, present, and future of vaccine production

1 Jan 2013

Abstract excerpt

Measles and mumps are common viral childhood diseases that can cause serious complications. Vaccination remains the most efficient way to control the spread of these viruses. The manufacturing capability for viral vaccines produced in embryonated hen eggs and conventional/classical cell substrates, such as chicken embryo fibroblast or primary dog kidney cell substrates, is no longer sufficient. This limitation...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to SARS-CoV-2 and COVID-19 Research
Share to Viral gastroenteritis research and epidemiology
Share to Virology and Viral Diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 23600866
DOI: 10.4149/av_2013_02_91

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Overview of measles and mumps vaccine: origin, present, and future of vaccine productionPMID 23600866Read ↗

Cell culture-derived influenza vaccines from Vero cells: a new horizon for vaccine productionSemantic proximity Read ↗

Platforms, advances, and technical challenges in virus-like particles-based vaccinesSemantic proximity Read ↗

Designing cell lines for viral vaccine production: Where do we stand?Semantic proximity Read ↗

Versatility of live-attenuated measles viruses as platform technology for recombinant vaccinesSemantic proximity Read ↗

Emerging Technologies for Low‐Cost, Rapid Vaccine ManufactureSemantic proximity Read ↗

Investigation of an atypically produced Jeryl Lynn mumps vaccineSemantic proximity Read ↗

Organoid as a culture system for viral vaccine strainsSemantic proximity Read ↗

Understanding the Measles Virus at 70 Years: From Cellular Mechanisms to Immunisation, 1954-2024Semantic proximity Read ↗

Innovations in cell culture-based influenza vaccine manufacturing – from static cultures to high cell density cultivationsSemantic proximity Read ↗

From single‐cell cloning to high‐yield influenza virus production – implementing advanced technologies in vaccine process developmentSemantic proximity Read ↗

Phenotypic and genomic analysis of serotype 3 Sabin poliovirus vaccine produced in MRC-5 cell substrate.Semantic proximity Read ↗

[Measles].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.